AU2002215982A1 - Topical treatment of mastalgia with arometese inhibitors such as androstendione - Google Patents

Topical treatment of mastalgia with arometese inhibitors such as androstendione

Info

Publication number
AU2002215982A1
AU2002215982A1 AU2002215982A AU1598202A AU2002215982A1 AU 2002215982 A1 AU2002215982 A1 AU 2002215982A1 AU 2002215982 A AU2002215982 A AU 2002215982A AU 1598202 A AU1598202 A AU 1598202A AU 2002215982 A1 AU2002215982 A1 AU 2002215982A1
Authority
AU
Australia
Prior art keywords
mastalgia
arometese
androstendione
inhibitors
topical treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215982A
Inventor
Alfred Schmidt
Heinrich Wieland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002215982(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU2002215982A1 publication Critical patent/AU2002215982A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Massaging Devices (AREA)

Abstract

A composition for medicinal treatment by means of topical administration is described, which contains an aromatase inhibitor, in addition to conventional constituents of topical forms of administration. The active ingredient or the composition containing this active ingredient is especially suitable for the prophylaxis and for the treatment of mastalgia.
AU2002215982A 2000-11-02 2001-10-30 Topical treatment of mastalgia with arometese inhibitors such as androstendione Abandoned AU2002215982A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054294A DE10054294A1 (en) 2000-11-02 2000-11-02 Topical treatment for mastalgia
DE10054294.8 2000-11-02
PCT/EP2001/012536 WO2002036129A2 (en) 2000-11-02 2001-10-30 Topical treatment of mastalgia with arometese inhibitors such as androstendione

Publications (1)

Publication Number Publication Date
AU2002215982A1 true AU2002215982A1 (en) 2002-05-15

Family

ID=7661891

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215982A Abandoned AU2002215982A1 (en) 2000-11-02 2001-10-30 Topical treatment of mastalgia with arometese inhibitors such as androstendione

Country Status (10)

Country Link
US (1) US20040018991A1 (en)
EP (1) EP1414467B1 (en)
AT (1) ATE324112T1 (en)
AU (1) AU2002215982A1 (en)
CY (1) CY1106319T1 (en)
DE (2) DE10054294A1 (en)
DK (1) DK1414467T3 (en)
ES (1) ES2263682T3 (en)
PT (1) PT1414467E (en)
WO (1) WO2002036129A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022342D0 (en) 2000-09-12 2000-10-25 Creative Peptides Sweden Ab Reduction of the electrocardiographic QT interval
EP1455697A4 (en) 2001-12-20 2009-08-05 Femmepharma Holding Co Inc Vaginal delivery of drugs
ES2263072T3 (en) * 2002-12-18 2006-12-01 Laboratoires Besins International TREATMENT OF MASTALGY WITH 4-HYDROXY TAMOXIFEN.
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
CA2764405A1 (en) 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
EP1875908A1 (en) * 2006-07-05 2008-01-09 Johannes Huber Use of Chrysin
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
US20080153789A1 (en) * 2006-12-26 2008-06-26 Femmepharma Holding Company, Inc. Topical administration of danazol
WO2008115413A1 (en) * 2007-03-16 2008-09-25 Meditrina Pharmaceuticals, Inc. Aromatase inhibitors for the treatment of mastalgia
US20100292150A1 (en) * 2007-12-10 2010-11-18 Meditrina Pharmaceuticals, Inc. Treatment of Menorrhagia with Aromatase Inhibitor
DE102008012988A1 (en) * 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Composition and uses for influencing hair growth
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2012104241A1 (en) 2011-01-31 2012-08-09 LUCOLAS-M.D. Ltd Combinations of aromatase inhibitors and antioxidants

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (en) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre ANTI-ESTROGEN MEDICINAL PRODUCT BASED ON 4-HYDROXYTAMOXIFENE FOR PERCUTANEOUS ADMINISTRATION
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
EP0342665A3 (en) * 1988-05-20 1990-08-16 Takeda Chemical Industries, Ltd. Physiologically active substance tan-931, its derivatives, their production and use
WO1992018132A1 (en) * 1991-04-17 1992-10-29 Merck & Co., Inc. Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
FR2677027B1 (en) * 1991-05-27 1993-09-10 Roussel Uclaf NEW STEROUID PRODUCTS SUBSTITUTED IN POSITION 6, AND COMPRISING, IN POSITION 10, A THIOETHYL RADICAL, THEIR PROCESS FOR THE PREPARATION OF THEIR INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS.
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
US5587392A (en) * 1994-05-27 1996-12-24 Mochida Pharmaceutical Co., Ltd. Azolyl methyl phenyl derivatives having aromatase inhibitory activity
NZ292940A (en) * 1994-09-14 1998-12-23 Univ Sheffield Use of an aromatase inhibitor and/or an androgen receptor anatonist as a cosmetic agent to reduce hair loss
DE59703511D1 (en) * 1996-03-29 2001-06-13 S W Patentverwaltungs Ges M B COSMETIC OR COSMETIC COMPOSITION FOR THE SMOOTHING AND TIGHTENING OF THE SKIN IN THE DISTURBATION OF UNDER-SKIN FABRIC ADHESIVE FABRIC, IN PARTICULAR WITH THE "CELLULITE"
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5906987A (en) * 1997-03-10 1999-05-25 Schering Aktiengesellschaft And Board Of Regents Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
EP0943333A1 (en) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6638727B1 (en) * 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
CA2380940C (en) * 1999-08-13 2013-06-25 Heinrich Wieland Substances and agents for positively influencing collagen

Also Published As

Publication number Publication date
DE10054294A1 (en) 2002-05-16
EP1414467A2 (en) 2004-05-06
DE50109650D1 (en) 2006-06-01
ATE324112T1 (en) 2006-05-15
WO2002036129A2 (en) 2002-05-10
CY1106319T1 (en) 2011-10-12
DK1414467T3 (en) 2006-08-28
ES2263682T3 (en) 2006-12-16
PT1414467E (en) 2006-09-29
US20040018991A1 (en) 2004-01-29
EP1414467B1 (en) 2006-04-26
WO2002036129A3 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HUP0301405A2 (en) Compositions containing therapeutically active components having enhanced solubility
MX2007006539A (en) System for improved percutaneous absorption of skin benefiting agents.
MY143795A (en) Tetrahydropyridoindole derivatives
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
AU2931500A (en) Pharmaceutical composition containing nitrate source and an acidifying agent fortreating skin ischaemia
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200621773A (en) Bicyclononene derivatives
TW200628468A (en) Bicyclononene derivatives
AU2001261516A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2003035080A3 (en) A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
NO20073575L (en) Pharmaceutical compositions for the treatment of cellulite
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
TW200621774A (en) Bicyclononene derivatives
WO2001070184A3 (en) A composition containing monoterpenes for topical oral administration